Article · 16 Sep 2026
Conference abstract
Improving the Accuracy and Comparability of Model-based Economic Evaluations of Pharmaceuticals for Reimbursement Decisions
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Increasingly, decision analytic models are used within economic evaluations of pharmaceuticals submitted to national reimbursement bodies in countries like UK and Australia, where such models play a fundamental role in informing public funding decisions. Estimates from decision analytic models are subject to various forms of uncertainty. This paper will focus on uncertainty specifically arising from the choice of model structure, a neglected area in guidelines developed by national reimbursement bodies, which is recognised as having a significant impact on the predictive ability of a model. We argue that the use of a reference model is an appropriate approach to address structural uncertainty affecting national reimbursement decisions. We propose a methodological framework for developing such models for specific diseases for economic evaluations of pharmaceuticals. The structure of the reference model reflects the natural history of the condition under study and defines the clinical events to be represented, the relationships between the events, and the effect of patient characteristics on the probability and timing of events. It is expected that the use of reference models will improve the accuracy and comparability of public funding decisions.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutica Analytica Acta.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hossein Afzali”
